Better vaccines, immune response with new additives
October 30, 2019
OHSU awarded $2.1 million to develop new adjuvants for Zika, Chikungunya viruses.
OHSU statement on animal research
October 04, 2019
OHSU believes that knowledge gained through biomedical research in relevant animal models is essential to developing new ways to identify, prevent, treat or eradicate disease and to improve human and animal health. OHSU’s views on this topic reflect those of other academic health centers, universities, physicians and scientists throughout the world.
New vaccine against tropical disease yellow fever to be tested
September 30, 2019
Clinical trial for OHSU’s HydroVax vaccine platform to start in 2020.
HIV vaccine nears clinical trial following new findings
July 17, 2019
Weakened form of vaccine still eliminates HIV-like virus in monkeys.
New partnership seeks to transform health care, graduate medical education in rural California, Oregon
June 05, 2019
American Medical Association grant will connect resident physicians to communities in need of more providers.
Vaccination saves lives
January 28, 2019
Declining vaccinations for nonmedical reasons endangers the health of our population's most vulnerable.
New vaccine offers fresh take on malaria fight
January 23, 2019
Cytomegalovirus-based vaccines also being tested for HIV and TB.
OHSU awarded $6.1 million to help improve quality of life for those with chronic lung infection
May 25, 2018
Researchers will test new treatment regimen to limit antibiotic use for MAC disease.
OHSU, CDC unravel mysterious eye infection
February 12, 2018
Oregon woman infected with cattle eyeworm species--the first known case in humans.
OHSU strongly refutes PETA allegations
January 31, 2018
Advertisements in D.C. publications make false claims about NIH-funded biomedical research at institutions nationwide, including Oregon National Primate Research Center.
